PP
OXFD

PDT Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

PDT Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,600
Closed -$372K – 907
2020
Q2 		$372K Buy
+28,600
New +$344K 0.03% 480

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PDT Partners's OXFD Position: Q3 2020 in Review

PDT Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2020, closing a stake of 28,600 shares — an estimated $372K sold.

PDT Partners first reported a position in OXFD in Q2 2020 and held it in 1 quarter. The position peaked at $372K in Q2 2020. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

  • PDT Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • PDT Partners sold 28,600 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2020, an estimated $372K.
  • PDT Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 1 quarter.
  • PDT Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $372K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on PDT Partners's 13F filing for Q3 2020, filed 16 Nov 2020.